Fulgent Genetics, Inc.

FLGT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$44-$175$142$506
Dep. & Amort.$25$26$33$11
Deferred Tax-$5$8$1-$8
Stock-Based Comp.$44$43$33$16
Change in WC-$7$3$2-$3
Other Non-Cash$8$123$43$16
Operating Cash Flow$21$27$254$539
Investing Activities
PP&E Inv.-$40-$22-$19-$24
Net Acquisitions$0-$0-$183-$62
Inv. Purchases-$472-$492-$433-$730
Inv. Sales/Matur.$454$553$373$270
Other Inv. Act.$0$1$0$0
Investing Cash Flow-$58$39-$261-$547
Financing Activities
Debt Repay.-$2-$20-$1-$0
Stock Issued$0$0$0$89
Stock Repurch.-$3-$28-$76-$4
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$5-$48-$77$85
Forex Effect-$0-$0-$0$0
Net Chg. in Cash-$42$18-$85$77
Supplemental Information
Beg. Cash$97$80$165$87
End Cash$55$97$80$165
Free Cash Flow-$19$5$235$515